iBio, Inc.
IBIO
$1.25
-$0.02-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.14% | 14.04% | -57.22% | -10.79% | -6.21% |
| Total Depreciation and Amortization | 0.00% | 3.73% | -16.61% | 1.40% | 1.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.11% | 2.57% | 821.69% | 15.69% | -28.37% |
| Change in Net Operating Assets | 362.17% | -275.88% | 249.72% | -6,712.50% | -99.28% |
| Cash from Operations | -2.37% | -16.08% | 7.48% | -22.75% | -48.63% |
| Capital Expenditure | -72.73% | 97.87% | -1,512.50% | -3,100.00% | 92.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.71% | -25.66% | 88.50% | -46,754.35% | -- |
| Cash from Investing | -41.82% | -4.29% | 86.12% | -47,862.22% | 421.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -283.75% | 12.57% | -3.98% |
| Issuance of Common Stock | 238.64% | 106.22% | 1,026.85% | -86.56% | 94.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -129.54% | 258.82% | -87.65% | 681.94% | -- |
| Cash from Financing | -31.08% | 220.48% | -81.19% | 470.97% | 669.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.77% | 3,279.50% | -97.13% | 441.47% | 275.58% |